Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

PAVM vs ISRG

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
PAVM
PAVmed Inc.

Medical - Devices

HealthcareNASDAQ • US
Market Cap$466M
5Y Perf.-76.1%
ISRG
Intuitive Surgical, Inc.

Medical - Instruments & Supplies

HealthcareNASDAQ • US
Market Cap$161.07B
5Y Perf.+134.6%

PAVM vs ISRG — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
PAVM logoPAVM
ISRG logoISRG
IndustryMedical - DevicesMedical - Instruments & Supplies
Market Cap$466M$161.07B
Revenue (TTM)$29K$10.58B
Net Income (TTM)$-6.32B$2.98B
Gross Margin-1729.1%66.3%
Operating Margin-167563.7%30.5%
Forward P/E14.4x43.8x
Total Debt$32M$303M
Cash & Equiv.$1M$3.37B

PAVM vs ISRGLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

PAVM
ISRG
StockMay 20May 26Return
PAVmed Inc. (PAVM)10023.9-76.1%
Intuitive Surgical,… (ISRG)100234.6+134.6%

Price return only. Dividends and distributions are not included.

Quick Verdict: PAVM vs ISRG

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: PAVM and ISRG are tied at the top with 3 categories each — the right choice depends on your priorities. Intuitive Surgical, Inc. is the stronger pick specifically for profitability and margin quality and capital preservation and lower volatility. As sector peers, any of these can serve as alternatives in the same allocation.
PAVM
PAVmed Inc.
The Growth Play

PAVM has the current edge in this matchup, primarily because of its strength in growth exposure.

  • Rev growth 22.1%, EPS growth 105.4%, 3Y rev CAGR 81.6%
  • 22.1% revenue growth vs ISRG's 20.5%
  • Lower P/E (14.4x vs 43.8x)
Best for: growth exposure
ISRG
Intuitive Surgical, Inc.
The Income Pick

ISRG is the clearest fit if your priority is income & stability and long-term compounding.

  • beta 1.02
  • 5.5% 10Y total return vs PAVM's -90.5%
  • Lower volatility, beta 1.02, Low D/E 1.7%, current ratio 4.87x
Best for: income & stability and long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthPAVM logoPAVM22.1% revenue growth vs ISRG's 20.5%
ValuePAVM logoPAVMLower P/E (14.4x vs 43.8x)
Quality / MarginsISRG logoISRG28.2% margin vs PAVM's -218K%
Stability / SafetyISRG logoISRGBeta 1.02 vs PAVM's 1.86
DividendsTieNeither stock pays a meaningful dividend
Momentum (1Y)PAVM logoPAVM+8.7% vs ISRG's -15.4%
Efficiency (ROA)ISRG logoISRG14.8% ROA vs PAVM's -166.0%, ROIC 15.0% vs -232.4%

PAVM vs ISRG — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

PAVMPAVmed Inc.
FY 2022
Royalty
100.0%$100M
ISRGIntuitive Surgical, Inc.
FY 2025
Instruments and Accessories
59.8%$6.0B
Systems
24.6%$2.5B
Services
15.6%$1.6B

PAVM vs ISRG — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLISRGLAGGINGPAVM

Income & Cash Flow (Last 12 Months)

ISRG leads this category, winning 6 of 6 comparable metrics.

ISRG is the larger business by revenue, generating $10.6B annually — 364900.0x PAVM's $29,000. ISRG is the more profitable business, keeping 28.2% of every revenue dollar as net income compared to PAVM's -217914.6%. On growth, ISRG holds the edge at +23.0% YoY revenue growth, suggesting stronger near-term business momentum.

MetricPAVM logoPAVMPAVmed Inc.ISRG logoISRGIntuitive Surgica…
RevenueTrailing 12 months$29,000$10.6B
EBITDAEarnings before interest/tax-$4.8B$3.8B
Net IncomeAfter-tax profit-$6.3B$3.0B
Free Cash FlowCash after capex-$4M$2.8B
Gross MarginGross profit ÷ Revenue-1729.1%+66.3%
Operating MarginEBIT ÷ Revenue-167563.7%+30.5%
Net MarginNet income ÷ Revenue-217914.6%+28.2%
FCF MarginFCF ÷ Revenue-123.5%+26.8%
Rev. Growth (YoY)Latest quarter vs prior year-99.5%+23.0%
EPS Growth (YoY)Latest quarter vs prior year-120.1%+18.8%
ISRG leads this category, winning 6 of 6 comparable metrics.

Valuation Metrics

Evenly matched — PAVM and ISRG each lead in 1 of 2 comparable metrics.

At 14.4x trailing earnings, PAVM trades at a 75% valuation discount to ISRG's 57.6x P/E.

MetricPAVM logoPAVMPAVmed Inc.ISRG logoISRGIntuitive Surgica…
Market CapShares × price$466M$161.1B
Enterprise ValueMkt cap + debt − cash$497M$158.0B
Trailing P/EPrice ÷ TTM EPS14.39x57.62x
Forward P/EPrice ÷ next-FY EPS est.43.84x
PEG RatioP/E ÷ EPS growth rate2.65x
EV / EBITDAEnterprise value multiple43.62x
Price / SalesMarket cap ÷ Revenue155.65x16.00x
Price / BookPrice ÷ Book value/share9.17x
Price / FCFMarket cap ÷ FCF64.67x
Evenly matched — PAVM and ISRG each lead in 1 of 2 comparable metrics.

Profitability & Efficiency

ISRG leads this category, winning 5 of 6 comparable metrics.

ISRG delivers a 16.9% return on equity — every $100 of shareholder capital generates $17 in annual profit, vs $-245 for PAVM. On the Piotroski fundamental quality scale (0–9), ISRG scores 6/9 vs PAVM's 5/9, reflecting solid financial health.

MetricPAVM logoPAVMPAVmed Inc.ISRG logoISRGIntuitive Surgica…
ROE (TTM)Return on equity-245.1%+16.9%
ROA (TTM)Return on assets-166.0%+14.8%
ROICReturn on invested capital-2.3%+15.0%
ROCEReturn on capital employed+16.5%
Piotroski ScoreFundamental quality 0–956
Debt / EquityFinancial leverage0.02x
Net DebtTotal debt minus cash$31M-$3.1B
Cash & Equiv.Liquid assets$1M$3.4B
Total DebtShort + long-term debt$32M$303M
Interest CoverageEBIT ÷ Interest expense-748.04x
ISRG leads this category, winning 5 of 6 comparable metrics.

Total Returns (Dividends Reinvested)

ISRG leads this category, winning 4 of 6 comparable metrics.

A $10,000 investment in ISRG five years ago would be worth $15,873 today (with dividends reinvested), compared to $1,092 for PAVM. Over the past 12 months, PAVM leads with a +871.3% total return vs ISRG's -15.4%. The 3-year compound annual growth rate (CAGR) favors ISRG at 14.4% vs PAVM's -0.8% — a key indicator of consistent wealth creation.

MetricPAVM logoPAVMPAVmed Inc.ISRG logoISRGIntuitive Surgica…
YTD ReturnYear-to-date-2.6%-19.3%
1-Year ReturnPast 12 months+871.3%-15.4%
3-Year ReturnCumulative with dividends-2.3%+49.6%
5-Year ReturnCumulative with dividends-89.1%+58.7%
10-Year ReturnCumulative with dividends-90.5%+554.2%
CAGR (3Y)Annualised 3-year return-0.8%+14.4%
ISRG leads this category, winning 4 of 6 comparable metrics.

Risk & Volatility

ISRG leads this category, winning 2 of 2 comparable metrics.

ISRG is the less volatile stock with a 1.02 beta — it tends to amplify market swings less than PAVM's 1.86 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ISRG currently trades 75.1% from its 52-week high vs PAVM's 25.1% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricPAVM logoPAVMPAVmed Inc.ISRG logoISRGIntuitive Surgica…
Beta (5Y)Sensitivity to S&P 5001.86x1.02x
52-Week HighHighest price in past year$28.44$603.88
52-Week LowLowest price in past year$0.21$427.84
% of 52W HighCurrent price vs 52-week peak+25.1%+75.1%
RSI (14)Momentum oscillator 0–10026.942.4
Avg Volume (50D)Average daily shares traded16K1.8M
ISRG leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.

Wall Street rates PAVM as "Buy" and ISRG as "Buy".

MetricPAVM logoPAVMPAVmed Inc.ISRG logoISRGIntuitive Surgica…
Analyst RatingConsensus buy/hold/sellBuyBuy
Price TargetConsensus 12-month target$622.60
# AnalystsCovering analysts355
Dividend YieldAnnual dividend ÷ price
Dividend StreakConsecutive years of raises1
Dividend / ShareAnnual DPS
Buyback YieldShare repurchases ÷ mkt cap0.0%+1.4%
Insufficient data to determine a leader in this category.
Key Takeaway

ISRG leads in 4 of 6 categories — strongest in Income & Cash Flow and Profitability & Efficiency. 1 category is tied.

Best OverallIntuitive Surgical, Inc. (ISRG)Leads 4 of 6 categories
Loading custom metrics...

PAVM vs ISRG: Frequently Asked Questions

9 questions · data-driven answers · updated daily

01

Is PAVM or ISRG a better buy right now?

For growth investors, PAVmed Inc.

(PAVM) is the stronger pick with 22. 1% revenue growth year-over-year, versus 20. 5% for Intuitive Surgical, Inc. (ISRG). PAVmed Inc. (PAVM) offers the better valuation at 14. 4x trailing P/E, making it the more compelling value choice. Analysts rate PAVmed Inc. (PAVM) a "Buy" — based on 3 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — PAVM or ISRG?

On trailing P/E, PAVmed Inc.

(PAVM) is the cheapest at 14. 4x versus Intuitive Surgical, Inc. at 57. 6x.

03

Which is the better long-term investment — PAVM or ISRG?

Over the past 5 years, Intuitive Surgical, Inc.

(ISRG) delivered a total return of +58. 7%, compared to -89. 1% for PAVmed Inc. (PAVM). Over 10 years, the gap is even starker: ISRG returned +554. 2% versus PAVM's -90. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — PAVM or ISRG?

By beta (market sensitivity over 5 years), Intuitive Surgical, Inc.

(ISRG) is the lower-risk stock at 1. 02β versus PAVmed Inc. 's 1. 86β — meaning PAVM is approximately 83% more volatile than ISRG relative to the S&P 500.

05

Which is growing faster — PAVM or ISRG?

By revenue growth (latest reported year), PAVmed Inc.

(PAVM) is pulling ahead at 22. 1% versus 20. 5% for Intuitive Surgical, Inc. (ISRG). On earnings-per-share growth, the picture is similar: PAVmed Inc. grew EPS 105. 4% year-over-year, compared to 22. 6% for Intuitive Surgical, Inc.. Over a 3-year CAGR, PAVM leads at 81. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — PAVM or ISRG?

PAVmed Inc.

(PAVM) is the more profitable company, earning 1329% net margin versus 28. 4% for Intuitive Surgical, Inc. — meaning it keeps 1329% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ISRG leads at 29. 3% versus -1485. 4% for PAVM. At the gross margin level — before operating expenses — ISRG leads at 66. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Which pays a better dividend — PAVM or ISRG?

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

08

Is PAVM or ISRG better for a retirement portfolio?

For long-horizon retirement investors, Intuitive Surgical, Inc.

(ISRG) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 02), +554. 2% 10Y return). PAVmed Inc. (PAVM) carries a higher beta of 1. 86 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (ISRG: +554. 2%, PAVM: -90. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

09

What are the main differences between PAVM and ISRG?

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

PAVM

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
Run This Screen
Stocks Like

ISRG

High-Growth Quality Leader

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 11%
  • Net Margin > 16%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform PAVM and ISRG on the metrics below

Revenue Growth>
%
(PAVM: -99.5% · ISRG: 23.0%)
P/E Ratio<
x
(PAVM: 14.4x · ISRG: 57.6x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.